PROGRAM CHAIR
Nicola A. Hanania, MD, MS, FCCP, FACP, FRCP(C), FERS
Professor of Medicine
Section of Pulmonary and Critical Care Medicine
Director, Airways Clinical Research Center
Baylor College of Medicine
Chief, Section of Pulmonary and Critical Care Medicine
Ben Taub Hospital
Houston, TX
PROGRAM DESCRIPTION
This enduring HoloVision™ activity is an online program designed to advance the abilities of US-based pulmonologists and respiratory therapists and provide the tools to determine an accurate diagnosis of COPD using new diagnostic methods; understand how interleukin (IL)-4/13 and IL-33 signaling pathways affect the pathophysiology of COPD; and review data from clinical studies of the clinical profiles of new and emerging treatments for COPD.
TARGET AUDIENCE
This educational activity is specifically designed for US-based pulmonologists and respiratory therapists involved in the diagnosis and management of patients with COPD.
LEARNING OBJECTIVES
- Facilitate a timely and accurate diagnosis of COPD using novel diagnostic methods
- Evaluate the roles of the interleukin (IL)-4/13 and IL-33 signaling pathways in the pathophysiology of COPD
- Assess data from studies investigating the clinical profiles of emerging therapies for the treatment of COPD
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Nicola A. Hanania, MD | Consulting Fees: AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim, Sanofi/Regeneron, and Genentech Research and Grant funding: National Heart, Lung, and Blood Institute (NHLBI), American Lung Association (ALA), GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Genentech, and Sanofi |
All relevant financial relationships have been mitigated.
Content Review
‘The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
- Tara Mayfield, Medical Director for Med Learning Group, has nothing to disclose.
- Russie Allen, Accreditation & Outcomes Manager for Med Learning Group, has nothing to disclose.
- Melissa Johnson, Program Manager for Med Learning Group, has nothing to disclose.
- Amanda Jenkins, Associate Program Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: March 01, 2024
EXPIRATION DATE: March 01, 2025
Copyright ©2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
